SDF-1/CXCR4 promotes F5M2 osteosarcoma cell migration by activating the Wnt/β-catenin signaling pathway

SDF-1/CXCR4 promotes epithelial–mesenchymal transition and progression of colorectal cancer by activation of the Wnt/β-catenin signaling pathway

(2014) Ting-hua Hu et al.   CANCER LETTERS

Breast cancer metastasis: demonstration that FOXP3 regulates CXCR4 expression and the response to CXCL12

(2014) Stephen Douglass et al.   JOURNAL OF PATHOLOGY

Hypoxia Promotes Migration and Induces CXCR4 Expression via HIF-1α Activation in Human Osteosarcoma

(2014) Mingjun Guo et al.   PLoS One

Inhibition of the Wnt-β-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapy

(2013) Yimin Ma et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Preclinical Development of a Novel Class of CXCR4 Antagonist Impairing Solid Tumors Growth and Metastases

(2013) Luigi Portella et al.   PLoS One

Combined Wnt/β-Catenin, Met, and CXCL12/CXCR4 Signals Characterize Basal Breast Cancer and Predict Disease Outcome

(2013) Jane D. Holland et al.   Cell Reports

SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial–mesenchymal transition in vitro through non-canonical activation of Hedgehog pathway

(2012) Xuqi Li et al.   CANCER LETTERS

Wnt/β-Catenin Signaling and Disease

(2012) Hans Clevers et al.   CELL

Role of the stromal-derived factor-1 (SDF-1)–CXCR4 axis in the interaction between hepatic stellate cells and cholangiocarcinoma

(2012) Alessandra Gentilini et al.   JOURNAL OF HEPATOLOGY

Common Musculoskeletal Tumors of Childhood and Adolescence

(2012) Carola A.S. Arndt et al.   MAYO CLINIC PROCEEDINGS

The Wnt signaling pathway: implications for therapy in osteosarcoma

(2011) Peter McQueen et al.   Expert Review of Anticancer Therapy

Strong expression of CXCL12 is associated with a favorable outcome in osteosarcoma

(2011) Daniel Baumhoer et al.   MODERN PATHOLOGY

MicroRNA-143 Regulates Human Osteosarcoma Metastasis by Regulating Matrix Metalloprotease-13 Expression

(2011) Mitsuhiko Osaki et al.   MOLECULAR THERAPY

Influence of CXCR4/SDF-1 axis on E-cadherin/β-catenin complex expression in HT29 colon cancer cells

(2011) Lin Wang   WORLD JOURNAL OF GASTROENTEROLOGY

CXCL12 (SDF-1)/CXCR4 Pathway in Cancer

(2010) B. A. Teicher et al.   CLINICAL CANCER RESEARCH

MicroRNA-155Regulates Cell Survival, Growth, and Chemosensitivity by TargetingFOXO3ain Breast Cancer

(2010) William Kong et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy

(2009) A. K. Azab et al.   BLOOD

Osteosarcoma incidence and survival rates from 1973 to 2004

(2009) Lisa Mirabello et al.   CANCER

Establishment and characterization of human osteosarcoma cell lines with different pulmonary metastatic potentials

(2009) Xiang Chen et al.   CYTOTECHNOLOGY

Stromal cell-derived factor-1/CXCR4 enhanced motility of human osteosarcoma cells involves MEK1/2, ERK and NF-κB-dependent pathways

(2009) Chun-Yin Huang et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Inactive Wnt/β-catenin pathway in conventional high-grade osteosarcoma

(2009) Yongping Cai et al.   JOURNAL OF PATHOLOGY

Chemokine Receptor CXCR4 Enhances Proliferation in Pancreatic Cancer Cells Through AKT and ERK Dependent Pathways

(2009) Xiaoming Shen et al.   PANCREAS